Salmanton-García, Jon ORCID: 0000-0002-6766-8297, Simon, Michaela, Groll, Andreas H ORCID: 0000-0003-1188-393X, Kurzai, Oliver, Lahmer, Tobias, Lehrnbecher, Thomas, Schroeder, Maria, Cornely, Oliver A ORCID: 0000-0001-9599-3137 and Stemler, Jannik ORCID: 0000-0001-9152-2469 (2024). Insights into invasive fungal infection diagnostic and treatment capacities in tertiary care centres of Germany. JAC-Antimicrobial Resistance, 6 (3). pp. 1-11. Oxford University Press. ISSN 2632-1823

[thumbnail of dlae083.pdf] PDF
dlae083.pdf
Bereitstellung unter der CC-Lizenz: Creative Commons Attribution.

Download (649kB)
Identification Number:10.1093/jacamr/dlae083

Abstract

[Artikel-Nr.: dlae083] Introduction: In Germany, the growing incidence of invasive fungal infections (IFIs) is a significant health concern, particularly impacting individuals with compromised immune systems due to factors like increasing transplant recipients, an ageing population, and heightened use of immunosuppressive medications. Diagnosing IFI remains challenging, and the integration of biomarker assays into clinical practice is difficult. Antifungal resistance, exemplified by pan-antifungal-resistant Candida auris cases, adds complexity to treatment. This study aims to provide a concise overview of the diagnostic and treatment landscape for IFI in Germany, identifying areas for improvement and paving the way for targeted interventions. Methods: Data were collected using an online electronic case report form from October 2021 to February 2023. The survey included questions about institutional practices related to fungal infection diagnosis and treatment, with invitations extended to researchers nationwide. Results: The study surveyed 58 hospitals across Germany. Notably, 77.6% managed high-risk patients for IFI. While 86% had onsite microbiology labs, a significant difference was noted for high-risk patients (93% in specialized hospitals versus 62% in others). Microscopy services had 96% coverage, while overall access to culture was 96%. Antigen tests had 96% coverage, and antibody access was reported at 98%. PCR testing was available at 98%. Imaging access showed no significant access differences. Variability existed in amphotericin B formulations based on patient profiles. Therapeutic drug monitoring was more common in high-risk patient institutions (89.5% versus 50.0%). All analysed institutions reported access to surgery (100%). Conclusions: Addressing identified disparities in diagnostic and therapeutic resources for IFI is crucial to improving patient outcomes. The study calls for ongoing research and collaboration to optimize strategies for the prevention and treatment of IFI, emphasizing the importance of equitable access to resources, especially in high-risk patient populations.

Item Type: Article
Creators:
Creators
Email
ORCID
ORCID Put Code
Salmanton-García, Jon
UNSPECIFIED
UNSPECIFIED
Simon, Michaela
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Groll, Andreas H
UNSPECIFIED
UNSPECIFIED
Kurzai, Oliver
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Lahmer, Tobias
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Lehrnbecher, Thomas
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Schroeder, Maria
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Cornely, Oliver A
UNSPECIFIED
UNSPECIFIED
Stemler, Jannik
UNSPECIFIED
UNSPECIFIED
URN: urn:nbn:de:hbz:38-816997
Identification Number: 10.1093/jacamr/dlae083
Journal or Publication Title: JAC-Antimicrobial Resistance
Volume: 6
Number: 3
Page Range: pp. 1-11
Number of Pages: 11
Date: 6 May 2024
Publisher: Oxford University Press
ISSN: 2632-1823
Language: English
Faculty: Central Institutions / Interdisciplinary Research Centers
Faculty of Medicine
Divisions: CECAD - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases
Faculty of Medicine > Innere Medizin > Klinik I für Innere Medizin - Hämatologie und Onkologie
Faculty of Medicine > Medizinische Mikrobiologie, Immunologie und Hygiene > Institut für Medizinische Mikrobiologie, Immunologie und Hygiene
Faculty of Medicine > Weitere > Centrum für integrierte Onkologie (CIO)
Faculty of Medicine > Weitere > Zentrum für Klinische Studien
Subjects: Life sciences
Medical sciences Medicine
['eprint_fieldname_oa_funders' not defined]: Publikationsfonds UzK
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/81699

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item